📰 Express Scripts News
Page 70 - Express Scripts News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Express Scripts. Real-time updates on events, politics, business and more.
May 23, 2023
Florida Gov. Ron DeSantis, 44, might be an unlikely candidate to wrest older GOP voters away from former President Donald Trump, a 76-year-old baby boomer. But he is trying.
May 23, 2023
While the top three PBMs’ aggregate share of claims was similar to the figures from 2021, the study indicated that Cigna’s share declined due to customer losses while OptumRx’s share grew slightly.
May 22, 2023
Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by then-President Donald Trump.
May 22, 2023
Memorial Day events will be happening May 29 in Butler and Warren counties. While most events are on that day, one Butler County area — Fairfield Twp.
May 22, 2023
Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration's push for lower drug prices at the pharmacy counter.
May 22, 2023
The agency's suit aiming to block Amgen's purchase of Horizon is its first lawsuit since 2009 trying to block a drug company merger.
May 22, 2023
The Florida governor is courting the large, politically influential group by pointing to his efforts to lower prescription drug prices. But his pitch can be lost on some voters.
May 22, 2023
There are several contractual provisions that sellers often use to limit their liability for post-closing claims brought by a buyer in the context of a private company purchase agreement.
May 22, 2023
As a 44-year-old member of Generation X, Gov. Ron DeSantis of Florida might be an unlikely candidate to wrest his party’s older voters away from former President Donald Trump, a 76-year-old baby boomer. But he is trying anyway.
May 20, 2023
To fight the skyrocketing cost of insulin, California is using multiple tactics, including making its own generic versions.